Bain Capital Life Sciences Investors, LLC Spring Works Therapeutics, Inc. Transaction History

Bain Capital Life Sciences Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $43.7 Million - $59.6 Million	-1,750,000 Reduced 36.22%	3,081,307 $79.3 Million
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $62.7 Million - $88.3 Million	-1,000,000 Reduced 17.15%	4,831,307 $306 Million
Q1 2021 May 17, 2021	SELL	$65.1 - $93.59 $94.4 Million - $136 Million	-1,450,000 Reduced 19.91%	5,831,307 $429 Million
Q3 2019 Nov 14, 2019	BUY	$18.8 - $27.82 $137 Million - $203 Million	7,281,307 New	7,281,307 $158 Million

239

70.8M

151K

255K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $3.58B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.